These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15968747)

  • 1. Nonalcoholic fatty liver disease in developing countries.
    Bahrami H
    World J Gastroenterol; 2005 Jun; 11(24):3808-9. PubMed ID: 15968747
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents.
    Dâmaso AR; do Prado WL; de Piano A; Tock L; Caranti DA; Lofrano MC; Carnier J; Cristofalo DJ; Lederman H; Tufik S; de Mello MT
    Dig Liver Dis; 2008 Feb; 40(2):132-9. PubMed ID: 18082476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.
    Duseja A; Sharma B; Kumar A; Kapil S; Das A; Dhiman RK; Chawla YK
    Hepatology; 2010 Dec; 52(6):2248-9. PubMed ID: 20725907
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease and the metabolic syndrome: an update.
    Rector RS; Thyfault JP; Wei Y; Ibdah JA
    World J Gastroenterol; 2008 Jan; 14(2):185-92. PubMed ID: 18186553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.
    Singh SP; Nayak S; Swain M; Rout N; Mallik RN; Agrawal O; Meher C; Rao M
    Trop Gastroenterol; 2004; 25(2):76-9. PubMed ID: 15471321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
    Milić S; Stimac D
    Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in pediatric patients.
    Sinatra FR
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):43S-8S. PubMed ID: 22237875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease in India--how much? How soon?
    Duseja A; Chawla Y
    Trop Gastroenterol; 2005; 26(1):1-3. PubMed ID: 15974230
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease and atherosclerosis.
    Targher G
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):e117; author reply e117-8. PubMed ID: 15980265
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Schindhelm RK; Heine RJ; Diamant M
    Diabetes Care; 2007 Sep; 30(9):e94; author reply e95. PubMed ID: 17726184
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies.
    Li Z; Xue J; Chen P; Chen L; Yan S; Liu L
    J Gastroenterol Hepatol; 2014 Jan; 29(1):42-51. PubMed ID: 24219010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.
    Lê KA; Bortolotti M
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):477-82. PubMed ID: 18542010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease: a nutritional approach.
    Colak Y; Tuncer I; Senates E; Ozturk O; Doganay L; Yilmaz Y
    Metab Syndr Relat Disord; 2012 Jun; 10(3):161-6. PubMed ID: 22394108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Targher G
    Hepatology; 2005 Oct; 42(4):974-5; discussion 975. PubMed ID: 16175589
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease in Asia: a story of growth.
    Wong VW
    J Gastroenterol Hepatol; 2013 Jan; 28(1):18-23. PubMed ID: 23094755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.
    Athyros VG; Katsiki N; Karagiannis A
    Angiology; 2013 Nov; 64(8):572-5. PubMed ID: 23508615
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
    Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.